Безопасен ли salix nigra bark extract при беременности?
No EU Annex II/III restriction or harmonised CLP reproductive classification was found. The CIR safety assessment of willow (Salix alba) bark extracts (used as the cosmetic reference in industry reviews) found no reproductive/developmental toxicity at doses up to 1000 mg/kg bw/day (NOAEL) and concluded willow-derived ingredients are safe in cosmetic use levels (reports list typical leave‑on use up to ~1.1%). However, the EMA herbal monograph notes that salicylates from willow products can cross the placenta and advises avoidance in pregnancy (and contraindication in the third trimester) for medicinal/oral use; this provides a theoretical mechanism of concern for systemic salicylates, though there is no direct evidence that typical topical cosmetic use leads to systemic levels causing reproductive effects. Sources: CIR (willow safety assessment), EMA monograph, EWG entry, PubMed reviews.
Pregnancy-safe products containing salix nigra bark extract









Related ingredients
Frequently asked questions
- Безопасен ли salix nigra bark extract при беременности?
- No EU Annex II/III restriction or harmonised CLP reproductive classification was found. The CIR safety assessment of willow (Salix alba) bark extracts (used as the cosmetic reference in industry reviews) found no reproductive/developmental toxicity at doses up to 1000 mg/kg bw/day (NOAEL) and concluded willow-derived ingredients are safe in cosmetic use levels (reports list typical leave‑on use up to ~1.1%). However, the EMA herbal monograph notes that salicylates from willow products can cross the placenta and advises avoidance in pregnancy (and contraindication in the third trimester) for medicinal/oral use; this provides a theoretical mechanism of concern for systemic salicylates, though there is no direct evidence that typical topical cosmetic use leads to systemic levels causing reproductive effects. Sources: CIR (willow safety assessment), EMA monograph, EWG entry, PubMed reviews.
- Безопасен ли salix nigra bark extract при грудном вскармливании?
- Same rationale as for pregnancy. CIR cosmetic assessment shows no reproductive/developmental hazard for willow bark extracts at tested doses; EMA states salicylates appear in breast milk after systemic (oral) exposure and therefore recommends caution for nursing mothers. For topical cosmetic use there is no direct evidence of harmful exposure via breast milk, but the theoretical transfer of salicylates after systemic absorption motivates a precautionary mechanism flag.
- Безопасен ли salix nigra bark extract для кожи малыша?
- No infant-specific reproductive/toxicology data were located. The parent safety assessment (CIR) did not identify reproductive hazards and did not require infant-specific restrictions; however, infant (0–3 yr) skin has higher permeability and higher surface‑area‑to‑weight, so exposure from topical products is increased (+1 exposure per your rules). There is no direct evidence that topical willow bark extracts at typical cosmetic use concentrations produce systemic salicylate levels in infants, but infants with immature barriers or products applied over large areas would have higher exposure.
- Как VeriMom оценивает salix nigra bark extract?
- VeriMom оценивает salix nigra bark extract в 87/100 (низкий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы salix nigra bark extract при беременности?
- См. наш список безопасных альтернатив salix nigra bark extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.